Overview

Reduced Dexamethasone Pre-Medication Dose in Elderly Patients Receiving Weekly Docetaxel

Status:
Terminated
Trial end date:
2007-04-01
Target enrollment:
Participant gender:
Summary
This study is to explore the feasibility of an alternative dose of dexamethasone pre-medication in older breast and lung cancer patients who are receiving weekly docetaxel chemotherapy.
Phase:
Phase 2
Details
Lead Sponsor:
Geriatric Oncology Consortium
Collaborator:
Sanofi
Treatments:
BB 1101
Dexamethasone
Dexamethasone 21-phosphate
Dexamethasone acetate
Docetaxel